Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

COVID-19 Updates:      COVID-19 Resources »      Vaccine Update »      Updated Visitor Policy »      What We're Doing to Keep You Safe »

Uveitis

Uveitis is an inflammation, or swelling and tenderness, of the middle layer of the eye. This area includes the colored part of the eye (iris), muscles, and blood vessels.

Uveitis may develop in people who have:

  • Other diseases that cause chronic inflammation, such as rheumatoid arthritis or inflammatory bowel disease.
  • A herpes infection that affects the eye.
  • Advanced-stage cataracts that leak fluid into the front (anterior) chamber of the eye. But most cataracts are treated before uveitis develops.

Treatment for uveitis depends on its cause.

Clinical Trials for Uveitis

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials